Developed & Manufactured by Biomedica
- Products
- By research area
- Bone Metabolism
- Cardiovascular
- Cell proliferation
- immunology
- Infectious disease
- Metabolic Disease
- Nephrology & Transplant
- Neurology
- Oncology
- Oxidative stress
- Toxicity
By product typeDeals of the month
Download biomedica product list
- Services
- ServicesDeals of the monthDownload biomedica product list
- Quality
- News
- About us
- Contact Us
- Downloads
Our ELISAs:
designed for your clinical
& preclinical application developed & manufactured
byFeatured Products & Promotions
FREE soluble RANKL HS ELISAHigh sensitivity – measurable concentrations in healthy subjectsLearn MoreOsteoprotegerin ELISADay testLearn MoreFGF23 (intact) human ELISACE-marked – for IVD use in the EULearn MoreLatest News-
Biomedica offers the FIRST fully validated VANIN-1 (urine) ELISA1 October, 2019Vanin-1 is a glycoprotein that is selectively expressed in renal tubular cells. Urinary Vanin-1 has as superior predictive value for drug induced AKI than KIM-1 or NGAL is a novel biomarker to detect and monitor the clinical course of obstructive nephropathy Related Literature & Findings: Urinary Vanin-1 As a Novel Biomarker for Early Detection of [...]
-
CE-mark for FGF23 (intact) human ELISA18 September, 2019Biomedica is proud to announce the launch of its CE-marked FGF23 (intact) human ELISA, cat# BI-20700 Features and Benefits RELIABLE & FULLY VALIDATED for plasma samples - according to ICH Q2 SERUM, URINE and CC SUPERNATANT are compatible with this ELISA FAST ONE-STEP ELISA - only 3.5 h total incubation time PLASMA BASED STANDARDS and CONTROLS INCLUDED [...]
-
FGF23 (intact) human ELISA as a featured product on Biocompare22 July, 2019The new intact FGF23 ELISA was mentioned in the most recent Biocompare newsletter as a featured product. Check out the drug discovery and development newsletter to learn more. FGF23 (intact) human ELISA Features and Benefits • RELIABLE and FULLY VALIDATED for plasma samples – according to ICH Q2 • SERUM, URINE and CC SUPERNATANT are compatible with [...]
Events-
Biomedica @ ASN7 November, 2019Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
-
Biomedica @ ASMBR18 September, 2019Meet us at the ASBMR in Orlando at The Biomedica booth # 516 Our Posters: #SUN-103, #SUN-271, #MON-252 and #MON-331 Tje Bone Turnover Markers Working Group Room# W307B, Sept 20 at 7:30pm Diurnal Changes in Serum Levels of Bone-Related Circulating MicroRNAs. Oral presentation #1140, room# W314, Monday, Sept 23 from 2:15pm-2:30pm If you cannot make it to the ASBMR [...]
-
Biomedica @ ICCBH in Salzburg17 June, 2019Meet Biomedica Immunoassays at poster P95 “Detection of intact FGF23 using a novel well-characterized ELISA” to learn more about new FGF23 (intact) human ELISA and to discuss your research projects! Useful links: Scientific Program FGF23 (intact) human ELISA